F5 executive sells 386 shares in planned trade

Q: What insider transaction did F5 (FFIV) report for Angelique M. Okeke?

Angelique M. Okeke reported selling 386 F5 common shares. The EVP and General Counsel executed an open-market sale at $278.32 per share on February 10, 2026, and now directly holds 1,874 F5 common shares following this single reported transaction.

Q: At what price were the F5 (FFIV) shares sold by EVP and General Counsel Angelique M. Okeke?

The reported sale price was $278.32 per share. On February 10, 2026, Angelique M. Okeke sold 386 shares of F5 common stock in an open-market transaction at this price, as disclosed in the Form 4 insider trading report.

Q: How many F5 (FFIV) shares does Angelique M. Okeke own after the reported sale?

She directly owns 1,874 F5 common shares after the sale. The Form 4 shows that, following the February 10, 2026 open-market sale of 386 shares, Angelique M. Okeke’s remaining beneficial ownership is 1,874 shares held in direct form.

Q: Was the F5 (FFIV) insider sale by Angelique M. Okeke under a Rule 10b5-1 plan?

Yes, the sale was made under a Rule 10b5-1 trading plan. The footnote states the transaction was executed pursuant to a Rule 10b5-1 plan dated October 30, 2025, indicating the trade was prearranged rather than decided at the time of sale.

Q: What role does Angelique M. Okeke hold at F5 (FFIV) in this Form 4 filing?

She is F5’s Executive Vice President and General Counsel. The Form 4 identifies her as an officer of the company with that title, and the reported transaction involves her directly held shares of F5 common stock.

F5, Inc. executive Angelique M. Okeke, EVP and General Counsel, sold 386 shares of F5 common stock in an open-market transaction at $278.32 per share on February 10, 2026.

Filing Impact

(Neutral)

Filing Sentiment

(Negative)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

F5, Inc. executive Angelique M. Okeke, EVP and General Counsel, sold 386 shares of F5 common stock in an open-market transaction at $278.32 per share on February 10, 2026. The sale was executed under a prearranged Rule 10b5-1 trading plan dated October 30, 2025.

After this transaction, she directly holds 1,874 shares of F5 common stock. The filing reflects a single discretionary trading-plan sale rather than a change in role or compensation.

Insider Trade Summary

Net Seller: 386 shares

Net Sell 1 txn

Insider OKEKE ANGELIQUE M

Role EVP, General Counsel

Sold 386 shs ($107K)

Type	Security	Shares	Price	Value
Sale	Common Stock	386	$278.32	$107K

Holdings After Transaction: Common Stock — 1,874 shares (Direct)

Footnotes (1)

F1. This transaction was executed pursuant to a Rule 10b5-1 trading plan dated 10/30/2025.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did F5 (FFIV) report for Angelique M. Okeke?

Angelique M. Okeke reported selling 386 F5 common shares. The EVP and General Counsel executed an open-market sale at $278.32 per share on February 10, 2026, and now directly holds 1,874 F5 common shares following this single reported transaction.

At what price were the F5 (FFIV) shares sold by EVP and General Counsel Angelique M. Okeke?

The reported sale price was $278.32 per share. On February 10, 2026, Angelique M. Okeke sold 386 shares of F5 common stock in an open-market transaction at this price, as disclosed in the Form 4 insider trading report.

How many F5 (FFIV) shares does Angelique M. Okeke own after the reported sale?

She directly owns 1,874 F5 common shares after the sale. The Form 4 shows that, following the February 10, 2026 open-market sale of 386 shares, Angelique M. Okeke’s remaining beneficial ownership is 1,874 shares held in direct form.

Was the F5 (FFIV) insider sale by Angelique M. Okeke under a Rule 10b5-1 plan?

Yes, the sale was made under a Rule 10b5-1 trading plan. The footnote states the transaction was executed pursuant to a Rule 10b5-1 plan dated October 30, 2025, indicating the trade was prearranged rather than decided at the time of sale.

What role does Angelique M. Okeke hold at F5 (FFIV) in this Form 4 filing?

She is F5’s Executive Vice President and General Counsel. The Form 4 identifies her as an officer of the company with that title, and the reported transaction involves her directly held shares of F5 common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 02/11/2026 - 05:20 PM EST

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

OKEKE ANGELIQUE M

(Last)

(First)

(Middle)

C/O F5, INC.

801 5TH AVENUE

(Street)

SEATTLE

98104

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
F5, INC. [ FFIV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	EVP, General Counsel

3. Date of Earliest Transaction (Month/Day/Year)
02/10/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	02/10/2026		S		386⁽¹⁾	D	$278.32	1,874	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. This transaction was executed pursuant to a Rule 10b5-1 trading plan dated 10/30/2025.

Remarks:

	/s/ Angelique M. Okeke	02/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR